134 related articles for article (PubMed ID: 37337131)
1. [Value of autocrine motility factors in the prediction of the disease progression of PBC- associated hepatocellular carcinoma].
Zhang MY; Xie H; Zhao J; Liang QS; Han L; Zhai XR; Li BS; Zou ZS; Sun Y
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):936-942. PubMed ID: 37337131
[No Abstract] [Full Text] [Related]
2. Hepatocellular Carcinoma in Primary Biliary Cholangitis.
Sy AM; Ferreira RD; John BV
Clin Liver Dis; 2022 Nov; 26(4):691-704. PubMed ID: 36270724
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for survival and the development of hepatocellular carcinoma in patients with primary biliary cirrhosis.
Tomiyama Y; Takenaka K; Kodama T; Kawanaka M; Sasaki K; Nishina S; Yoshioka N; Hara Y; Hino K
Intern Med; 2013; 52(14):1553-9. PubMed ID: 23857086
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.
Bosch DE; Zen Y; Boukhar SA; Liu Y; Cheng L; Yeh MM
Virchows Arch; 2021 Dec; 479(6):1131-1143. PubMed ID: 34414507
[TBL] [Abstract][Full Text] [Related]
5. Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factors.
Zhang XX; Wang LF; Jin L; Li YY; Hao SL; Shi YC; Zeng QL; Li ZW; Zhang Z; Lau GK; Wang FS
World J Gastroenterol; 2015 Mar; 21(12):3554-63. PubMed ID: 25834320
[TBL] [Abstract][Full Text] [Related]
6. Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
Natarajan Y; Tansel A; Patel P; Emologu K; Shukla R; Qureshi Z; El-Serag HB; Thrift AP; Kanwal F
Dig Dis Sci; 2021 Jul; 66(7):2439-2451. PubMed ID: 32743773
[TBL] [Abstract][Full Text] [Related]
7. Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis.
John BV; Dahman B; Deng Y; Khakoo NS; Taddei TH; Kaplan DE; Levy C
Liver Int; 2022 Feb; 42(2):384-393. PubMed ID: 34614294
[TBL] [Abstract][Full Text] [Related]
8. Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study.
Trivedi PJ; Lammers WJ; van Buuren HR; Parés A; Floreani A; Janssen HL; Invernizzi P; Battezzati PM; Ponsioen CY; Corpechot C; Poupon R; Mayo MJ; Burroughs AK; Nevens F; Mason AL; Kowdley KV; Lleo A; Caballeria L; Lindor KD; Hansen BE; Hirschfield GM;
Gut; 2016 Feb; 65(2):321-9. PubMed ID: 25567117
[TBL] [Abstract][Full Text] [Related]
9. Obeticholic acid for the treatment of primary biliary cholangitis.
Ali AH; Lindor KD
Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Braga MH; Cançado GGL; Bittencourt PL; Couto CA; Guedes LV; Lima AMC; Ferraz MLG; Villela-Nogueira CA; Nardelli MJ; Faria LC; Gomes NMF; Oliveira EMG; Rotman V; Oliveira MB; da Cunha SMCF; Cunha-Silva M; Mendes LSC; Ivantes CAP; Codes L; de Almeida E Borges VF; Pace FHL; Pessoa MG; Signorelli IV; Coral GP; Filho JG; Chagas AL; Terrabuio DRB; Cançado ELR;
Ann Hepatol; 2023; 28(4):101105. PubMed ID: 37088418
[TBL] [Abstract][Full Text] [Related]
11. Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis.
Joshita S; Umemura T; Usami Y; Yamashita Y; Norman GL; Sugiura A; Yamazaki T; Fujimori N; Kimura T; Matsumoto A; Igarashi K; Yoshizawa K; Ota M; Tanaka E
Sci Rep; 2018 May; 8(1):8159. PubMed ID: 29802350
[TBL] [Abstract][Full Text] [Related]
12. Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update.
Bowlus CL; Kenney JT; Rice G; Navarro R
J Manag Care Spec Pharm; 2016 Oct; 22(10-a-s Suppl):S3-S15. PubMed ID: 27700211
[TBL] [Abstract][Full Text] [Related]
13. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in a male patient with early stage (stage I) primary biliary cirrhosis.
Kadokawa Y; Omagari K; Ohba K; Kitamura S; Ohara H; Takeshima F; Mizuta Y; Nanashima A; Yamaguchi H; Kohno S
Intern Med; 2005 Mar; 44(3):207-11. PubMed ID: 15805708
[TBL] [Abstract][Full Text] [Related]
15. Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease.
Cortez-Pinto H; Liberal R; Lopes S; Machado MV; Carvalho J; Dias T; Santos A; Agostinho C; Figueiredo P; Loureiro R; Martins A; Alexandrino G; Cotrim I; Leal C; Presa J; Mesquita M; Nunes J; Gouveia C; Vale AHE; Alves AL; Coelho M; Maia L; Pedroto I; Banhudo A; Pinto JS; Gomes MV; Oliveira J; Andreozzi V; Calinas F
United European Gastroenterol J; 2021 Jul; 9(6):699-706. PubMed ID: 34102008
[TBL] [Abstract][Full Text] [Related]
16. Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis.
Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF
World J Gastroenterol; 2017 Nov; 23(44):7863-7874. PubMed ID: 29209127
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis.
Gatselis NK; Goet JC; Zachou K; Lammers WJ; Janssen HLA; Hirschfield G; Corpechot C; Lindor KD; Invernizzi P; Mayo MJ; Battezzati PM; Floreani A; Pares A; Lygoura V; Nevens F; Mason AL; Kowdley KV; Ponsioen CY; Bruns T; Thorburn D; Verhelst X; Harms MH; van Buuren HR; Hansen BE; Dalekos GN;
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):684-692.e6. PubMed ID: 31419573
[TBL] [Abstract][Full Text] [Related]
18. Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis complicated with atypical hepatocellular carcinoma: a case report.
Surdea-Blaga T; Cărăguț RL; Caraiani C; Spârchez Z; Al Hajjar N; Dumitrașcu DL
J Med Case Rep; 2023 Jul; 17(1):328. PubMed ID: 37488645
[TBL] [Abstract][Full Text] [Related]
19. Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis.
Deutsch M; Papatheodoridis GV; Tzakou A; Hadziyannis SJ
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):5-9. PubMed ID: 18090982
[TBL] [Abstract][Full Text] [Related]
20. Decreased infiltration of CD4
Yu K; Li P; Xu T; Xu J; Wang K; Chai J; Zhao D; Liu Y; Wang Y; Ma J; Fan L; Guo S; Li Z; Li M; Wang Z
Pathol Res Pract; 2021 Jan; 217():153291. PubMed ID: 33249399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]